A case of severe cancer-related pulmonary hypertension; An unexpected resolution

Respir Med Case Rep. 2022 May 23:38:101671. doi: 10.1016/j.rmcr.2022.101671. eCollection 2022.

Abstract

Pulmonary hypertension (PH) in cancer patients can be caused by several mechanisms. It can be a direct cancer effect through pulmonary tumor thrombotic microangiopathy, pulmonary tumor emboli, extrinsic compression, intravascular tumors, or a secondary consequence of therapy, including chemotherapy agents, radiation, and stem cell transplantation. We present the first case of complete resolution of cancer-related PH.

Keywords: Cancer; Lymphoma; Pulmonary hypertension; Pulmonary tumor thrombotic microangiopathy; Pulmonary veno-occlusive disease; Resolution.

Publication types

  • Case Reports